DAPAVIB S 10 "DAPAGLIFLOZIN 10mg. IP + SITAGLIPTIN PHOSPHATE 100mg. IP

Dapavib S 10 tablets combine Dapagliflozin 10 mg and Sitagliptin Phosphate 100 mg to improve glycemic control in type 2 diabetes. Main uses: adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus; helps lower blood sugar in adults with type 2 diabetes mellitus; used as a once-daily tablet in the management of type 2 diabetes mellitus.

Common side effects of Dapavib S 10 Tablet include female genital mycotic infections; nasopharyngitis; urinary tract infections; upper respiratory tract infection; headache; genital mycotic infections. Get medical help at once if you notice diabetic ketoacidosis; patients should be assessed for ketoacidosis regardless of presenting blood glucose levels, as it can occur even when blood glucose is not high; necrotising fasciitis of the perineum (Fournier's gangrene); acute pancreatitis.

Each Dapavib S 10 tablet contains Dapagliflozin 10 mg + Sitagliptin Phosphate 100 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Dapavib S 10 Tablet only as your doctor advises.

The MRP of Dapavib S 10 Tablet is ₹176 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹134.1 and the PTS is ₹120.69.

Each Dapavib S 10 tablet contains Dapagliflozin 10 mg + Sitagliptin Phosphate 100 mg. It comes in a pack of 10x10 (Alu Alu).

Dapagliflozin works on the kidneys to reduce the reabsorption of filtered glucose, so extra sugar leaves the body through urine. Sitagliptin slows the breakdown of incretin hormones after meals, helping the pancreas release insulin and helping control blood sugar levels.

Must not be used by patients with a history of a serious hypersensitivity reaction to dapagliflozin, sitagliptin or any of the excipients. Must not be used by patients with type 1 diabetes mellitus. Check with a doctor first: patients with kidney impairment or reduced eGFR, as the dapagliflozin part may be ineffective. Check with a doctor first: elderly patients, patients with low blood pressure, dehydration or those taking diuretics, as volume depletion may occur; volume status and kidney function should be assessed before starting and monitored during treatment. Check with a doctor first: patients with a history of pancreatitis, heart failure risk factors, or those taking insulin or a sulfonylurea.

Dapavib S 10 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.